Post-translational histone modifications have a critical role in regulating transcription, the cell cycle, DNA replication and DNA damage repair 1 . The identification of new histone modifications critical for transcriptional regulation at initiation, elongation or termination is of particular interest. Here we report a new layer of regulation in transcriptional elongation that is conserved from yeast to mammals. This regulation is based on the phosphorylation of a highly conserved tyrosine residue, Tyr 57, in histone H2A and is mediated by the unsuspected tyrosine kinase activity of casein kinase 2 (CK2). Mutation of Tyr 57 in H2A in yeast or inhibition of CK2 activity impairs transcriptional elongation in yeast as well as in mammalian cells. Genome-wide binding analysis reveals that CK2a, the catalytic subunit of CK2, binds across RNA-polymerase-II-transcribed coding genes and active enhancers. Mutation of Tyr 57 causes a loss of H2B mono-ubiquitination as well as H3K4me3 and H3K79me3, histone marks associated with active transcription. Mechanistically, both CK2 inhibition and the H2A(Y57F) mutation enhance H2B deubiquitination activity of the Spt-Ada-Gcn5 acetyltransferase (SAGA) complex, suggesting a critical role of this phosphorylation in coordinating the activity of the SAGA complex during transcription. Together, these results identify a new component of regulation in transcriptional elongation based on CK2-dependent tyrosine phosphorylation of the globular domain of H2A.
To assess potential tyrosine phosphorylation events in H2A, we individually mutated every tyrosine residue in H2A to phenylalanine and expressed the mutants in 293T cells. Mutation of Tyr 39 and Tyr 57 resulted in a decrease in tyrosine phosphorylation compared to the wild-type protein, indicating that these residues might be phosphorylated ( Fig. 1a ). Mass spectrometry confirmed phosphorylation of these residues in histone extracts from 293T cells ( Supplementary Table 1 ). The Tyr 57 residue, along with neighbouring residues, is conserved from yeast to mammals (Fig. 1b) , and is present in all variants of H2A (Extended Data Fig. 1a ). In budding yeast, where genetic manipulation of histones is possible, mutation of the corresponding residue to alanine is lethal, suggesting a critical structural and/or functional contribution of this tyrosine residue 2,3 . Analysis of histones in wild-type mononucleosomes and those containing the H2A(Y57F) mutant showed similar stoichiometry, suggesting that the Y57F mutation is unlikely to affect the structural integrity of nucleosomes (Extended Data Fig. 1b ). Hence, we tested whether the structurally conservative substitution of tyrosine with phenylalanine would produce a different phenotype in yeast. Tyr 58 in yeast H2A corresponds to Tyr 57 in mammalian H2A. The H2A(Y58F) mutant was viable and exhibited a slow growth phenotype (Fig. 1c) . Notably, the same mutation proved to be lethal in the HTZ1 (the gene encoding H2AZ (also known as H2AFZ)) null background, and double mutation of the tyrosine residue in both H2A and H2AZ resulted in an extremely slow growth phenotype ( Fig. 1c and Extended Data Fig. 1c ). Next, we tested if this site is phosphorylated in yeast. Immunoprecipitated Flagtagged H2A(Y58F) showed reduced tyrosine phosphorylation compared to the wild-type protein ( Fig. 1d ), suggesting that this residue is phosphorylated.
To confirm Tyr 57 phosphorylation and investigate its function, an antibody specific for phosphorylated Tyr (pTyr) 57 H2A was developed. This antibody detected proteins corresponding to the size of H2A and ubiquitinated H2A in 293T cells (Extended Data Fig. 1d ). Peptide blocking assays and dot blot assays verified the specificity of the antibody and treatment with calf intestinal phosphatase further validated its phosphospecificity (Extended Data Fig. 1d-f ). Use of this antibody confirmed Tyr 58 phosphorylation in yeast H2A (Fig. 1e ). Collectively, these results demonstrate that Tyr 57 in H2A is phosphorylated and that this phosphorylation is conserved from yeast to mammals.
To identify the kinase(s) that mediate(s) phosphorylation of Tyr 57 in H2A in mammals, we performed mass spectrometry analysis of proteins interacting with H2A in 293T cells. To be consistent with yeast, we used H2AX (also known as H2AFX), a common H2A variant that has closer sequence homology to yeast H2A, for co-immunoprecipitation and in vitro kinase assays. Mass spectrometry data revealed that the CK2a catalytic subunit of CK2 interacts preferentially with H2A(Y57F) compared to wild-type H2A ( Supplementary Table 2 ). This interaction was further verified by immunoblotting, which revealed a higher level of CK2a associated with H2A(Y57F) ( Fig. 2a ). One implication of this interaction is that CK2 may phosphorylate Tyr 57 in H2A, and the Y57F mutation stabilizes the enzyme-substrate interaction, analogous to substrate trapping approaches that have been successfully used to identify substrates of tyrosine phosphatases 4 . Although CK2 is considered primarily to be a Ser/Thr kinase, two studies have reported its tyrosine phosphorylation activity, thus implicating it as a dual-specificity kinase 5, 6 . To investigate the potential roles of CK2 in H2A Tyr 57 phosphorylation, we tested whether CK2a phosphorylates the tyrosine residue (Tyr 57) in H2A in an in vitro assay using full-length H2A or nucleosomes. The kinase assay revealed that CK2a phosphorylates Tyr 57 in H2A, acting preferentially in the context of nucleosomes (Fig. 2b ). This phosphorylation was inhibited by tetrabromobenzimidazole (TBBz), a chemical inhibitor of CK2 7 . To further establish the tyrosine kinase activity of CK2a, we performed phosphoamino acid analysis (PAA) of phosphorylated H2A from nucleosomes using [c-32 P]ATP. We found that CK2a phosphorylates tyrosine as well as serine residues in H2A, but does not phosphorylate threonine residues, and that Tyr 57 is a phosphorylation site, as demonstrated by the reduced tyrosine phosphorylation in H2A(Y57F) compared to wild-type H2A (Extended Data Fig. 2a ).
Next we investigated whether CK2 is necessary for H2A Tyr 57 phosphorylation in vivo. CK2a knockdown in 293T cells reduced the level of Tyr 57 phosphorylation in H2A ( Fig. 2c ), supporting an in vivo role of CK2a in regulating this phosphorylation. Moreover, a dose-dependent decrease in H2A Tyr 57 phosphorylation was observed upon treatment with TBBz ( Fig. 2d ), further supporting the role of CK2 in Tyr 57 phosphorylation in H2A. Together, these results provide strong evidence for a function of CK2 in H2A Tyr 57 phosphorylation.
To investigate the physiological significance of Tyr 57 phosphorylation in H2A, we examined in yeast the impact of the H2A(Y58F) mutation on other important histone marks. We found that the H2A(Y58F) mutation resulted in a loss of H2B mono-ubiquitination, as well as trimethylation of H3K4 and H3K79 ( Fig. 3a) . H3K27 acetylation showed a modest increase, and all other histone modifications tested were unaffected (Extended Data Fig. 3a) . Notably, the Y57F mutation also lowered the level of H2A mono-ubiquitination in 293T cells (Extended Data Fig. 3b , c). The role of H2A Tyr 58 phosphorylation as a potential regulator of H2B mono-ubiquitination is of particular significance because this modification has an established role in transcriptional elongation 8, 9 , thus potentially linking H2A Tyr 58 phosphorylation to transcriptional elongation. Further, yeast with the H2A(Y58F) mutation exhibited increased sensitivity to 6-azauracil (Extended Data Fig. 3d ), indicating a defect in transcriptional elongation 10 .
To assess the role of Tyr 58 phosphorylation in transcriptional elongation, binding of RNA polymerase II (Pol II) in actively transcribed genes was evaluated by chromatin immunoprecipitation (ChIP) followed by quantitative real-time polymerase chain reaction (qPCR). Pol II binding was reduced in the gene body of a housekeeping gene, PYK1, as well as a number of heat-shock-induced genes 11 upon heat shock in the H2A(Y58F) mutant ( Fig. 3b ). Pol II binding was further reduced in H2A(Y58F) and H2AZ(Y65F) mutants (Fig. 3b ). The decrease in Pol II binding in the H2A(Y58F) mutant was not due to reduced Pol II expression (Extended Data Fig. 3e ). Consistent with the defect in transcriptional elongation, a decreased level of messenger RNA of the corresponding genes was observed in H2A(Y58F) mutants (Extended Data Fig. 3f ), whereas H2AZ(Y65F) mutation alone caused only a mild defect in transcription of heat-shockinduced genes (Extended Data Fig. 3g ). Furthermore, in 293T cells, H2A Tyr 57 phosphorylation, like H2B mono-ubiquitination, was correlated with transcriptional elongation events, as demonstrated when transcriptional elongation was blocked with flavopiridol treatment 12 , and induced by washing out the drug (Extended Data Fig. 3h ). H3K4me2, a control histone mark, did not change in this assay (Extended Data Fig. 3h ). Collectively, these results indicate a conserved role of Tyr 57/58 phosphorylation in H2A in regulating transcriptional elongation. 
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To address the mechanism through which H2A Tyr 57/58 phosphorylation regulates H2B mono-ubiquitination, we examined the recruitment of proteins known to be involved in establishing H2B mono-ubiquitination, such as Paf1, Rtf1 and Rad6 (refs 13-15) , by ChIP-qPCR. The binding of Paf1 and Rtf1 was comparable in wild-type and H2A(Y58F) yeast strains, whereas Rad6 binding was slightly reduced in the genes tested in the H2A(Y58F) mutant strain (Extended Data Fig. 4a-c) . The effect of the H2A(Y58F) mutation was further evaluated in yeast lacking UBP8, which encodes a major H2B deubiquitinase that is a component of the SAGA complex. Deletion of UBP8 restored H2B mono-ubiquitination in the H2A(Y58F) mutant to the wild-type level ( Fig. 3c ), suggesting that the defect in H2B mono-ubiquitination in the H2A(Y58F) mutant occurs through Ubp8 deubiquitinase activity, and not through defective ubiquitination machinery. Likewise, CK2 inhibition reduced H2B monoubiquitination in wild-type yeast while having no effect in UBP8 mutants ( Fig. 3d ), further supporting the role of CK2-mediated H2A Tyr 58 phosphorylation in preventing H2B deubiquitination. Notably, despite the complete rescue of H2B mono-ubiquitination, UBP8 deletion only partially rescued H3K79me3, and the level of H3K4me3 remained low in the H2A(Y58F) mutant (Fig. 3c ). Furthermore, deletion of UBP8 did not rescue defects in Pol II binding, the transcript levels, or the slow growth phenotype of the H2A(Y58F) mutant (Extended Data Fig. 4d-f ). These results suggest that the physiological effects of Tyr 58 mutation in H2A are linked to, but extend beyond, the loss of H2B mono-ubiquitination.
Next, we investigated whether knockdown or inhibition of CK2 phenocopies the effects of H2A(Y58F) mutation in the regulation of transcriptional elongation. Consistent with the result in yeast, H2B monoubiquitination was reduced upon CK2a knockdown or inhibition of CK2 kinase activity in 293T cells ( Fig. 2c, d) . Likewise, Pol II binding in active genes in LNCaP human prostate carcinoma cells was impaired in gene bodies but not in the promoter regions upon CK2 inhibition, as determined by ChIP followed by sequencing (ChIP-seq) (Fig. 4a) . A travelling ratio plot of Pol II 16, 17 showed a significant shift in CK2-inhibited cells ( Fig. 4a ), suggesting that CK2 kinase activity is required for transcriptional elongation in gene bodies. In agreement with this, dihydrotestosterone (DHT)-induced transcriptional activation of androgen-receptor-regulated genes was impaired in LNCaP cells treated with TBBz (Extended Data Fig. 5a ).
To understand the molecular aspects of the role of CK2 in transcriptional elongation, genome-wide localization of CK2a in LNCaP cells was determined by ChIP-seq. Like Pol II, CK2a showed binding to actively transcribed genes across gene bodies, although its binding profile was distinct from that of Pol II (Fig. 4b) . Meta-analysis of the top 10% of active genes, based on global run-on sequencing results in LNCaP cells 18 , revealed that CK2a globally co-localizes with Pol II (Fig. 4c) . Consistent with the genome-wide binding pattern, CK2a immunoprecipitated with the phosphorylated carboxy-terminal domain (CTD) of Pol II, which is localized in the promoters (pSer 5) and gene bodies (pSer 2) of active genes (Extended Data Fig. 5b ). We also found CK2a binding in intergenic regions that co-localized with H3K4me1 and H3K27ac marks, histone modifications that co-localize with active enhancers 19 , and LNCaP celltype-specific androgen receptor enhancers ( Fig. 4d and Extended Data Fig. 5c ), suggesting that the intergenic CK2a peaks are in enhancer regions. Inhibition of CK2 also caused stalling of Pol II in the androgenreceptor-bound enhancers (Fig. 4e, Extended Data Fig. 5d ), underpinning the function of CK2 in transcriptional elongation in both gene bodies and enhancers.
We asked if CK2 also regulates transcriptional elongation in yeast, and if so, whether H2A Tyr 58 phosphorylation is a key player, among the many other substrates of CK2 20 . Inhibition of CK2 kinase activity resulted in a decrease in the recruitment of Pol II in both the promoter region as well as gene bodies of the tested genes in wild-type yeast, but did not have additive effects in the H2A(Y58F) yeast (Fig. 4f ). It is noteworthy that both CK2 inhibition and H2A(Y58F) mutation did not result in promoter-proximal pausing in the genes tested, consistent with the observation that regulation by promoter-proximal pausing is rare in yeast 21 . Collectively, these results demonstrate that CK2 has a deeply conserved role in transcriptional elongation both in gene bodies and enhancers, and that H2A Tyr 58 phosphorylation is critical in this regulation.
This study identifies a new H2A modification, phosphorylation of Tyr 57/58, which provides new insight into how two important protein complexes, SAGA and Paf1, with opposite enzymatic effects on H2B monoubiquitination, might be coordinated during transcriptional elongation. The data further emphasize the key significance of this delicate coordination as demonstrated by defects in transcriptional elongation upon mutation of the conserved phosphorylation site. A moderate increase 
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in Gcn5-SAGA-mediated H3K27 acetylation 22 in the H2A(Y58F) mutant yeast suggests that phosphorylation may antagonize multiple activities of SAGA. Such antagonism could explain the partial rescue of the defects in the H2A(Y58F) mutant upon deletion of UBP8, as the other modules of SAGA remain functional in the absence of Ubp8 23 . Although unlikely, the potential role in transcriptional elongation of the hydroxyl group of Tyr 58, rather than phosphorylation itself, cannot yet be dismissed. Assays using synthetic nucleosomes with constitutively phosphorylated H2A Tyr 57/58 may ultimately be used to further define the role of this site in transcriptional elongation. This study also emphasizes the functional significance of the tyrosine kinase activity of CK2, and encourages the search for other tyrosine substrates of CK2. Importantly, the identification of a highly conserved role of CK2 in regulating transcriptional elongation in both gene bodies and enhancer regions adds yet another layer to understanding transcription.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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METHODS
Cell culture, short interfering RNA, primers, plasmids, transfection, antibodies and kinase inhibitors. LNCaP and 293T cells were cultured in F12 medium supplemented with 10% fetal bovine serum (FBS) and glutamine. For the DHTtreatment experiments, LNCaP cells were cultured in deficient DME high glucose medium with 5% FBS (charcoal dextran filtered) for 3-4 days. Short interfering RNA (siRNA) against CK2a was from Santa Cruz (sc-29918). Cells were transfected using lipofectamine 2000 (Invitrogen) using the manufacturer's protocol. Mutagenesis was done using Quikchange Lightening Mutagenesis Kit following the manufacturer's recommended protocol. The following antibodies were used in this study: pTyr 57 H2A antibody was generated by Biomatik Company using pTyr 57 H2A peptide as an antigen (LE(pY)LTAEILELAGNC), purified, and positively selected using a pTyr 57 H2A peptide column, and negatively selected using a TBBz and flavopiridol were from Sigma. Primers used in this study are listed in Supplementary Table 3 . Chromatin immunoprecipitation. Cells were grown to 90-95% confluence, fixed with 1% formaldehyde for 15 min for Pol II ChIP, and with di-succinimidyl glutarate (DSG) for 45 min followed by 10 min fixation with 1% formaldehyde for CK2a ChIP. Fixations were performed at room temperature. To terminate crosslinking, fixed cells were incubated with glycine (1.25 mM) for 10 min. Nuclei were prepared as described 25 , which were then sonicated in lysis buffer (150 mM NaCl, 1% Triton X-100, 20 mM Tris pH 8.0, 0.1% SDS) using a Bioruptor to fragment chromatin to less than 500 base pairs (bp). Chromatin was pre-cleared with Protein-G magnetic beads, and then immunoprecipitated using 5 mg of antibody per 10-cm plate for each sample. The chromatin antibody mix was incubated with 35 ml protein G-conjugated Dyna beads for 4 h at 4 uC, washed three times with wash buffer (1% Triton X-100, 50 mM Tris pH 8.0, 10% glycerol) with increasing concentrations of NaCl (150 mM, 300 mM and 400 mM), and two times with Tris-EDTA buffer. DNA was eluted in 1% SDS in Tris-EDTA buffer for 45 min at 37 uC, crosslinking was reversed overnight at 65 uC, and DNA was purified using Qiagen columns. Yeast ChIP was performed using 300-400 mg DNA and 2 mg antibody using the protocol as described 26 with some modifications. In brief, cells were fixed for 15 min, and then incubated with glycine at a final concentration of 2.5 mM for 5 min, and cells were lysed using glass beads (5 3 5 min beating with 2 min on ice intervals). Cells were then sonicated to obtain chromatin fragments of less than 1 kb, and the rest of the protocol was similar to the mammalian cells. All the buffers used included fresh complete protease inhibitors (Roche), 1 mM PMSF, 2 mM Na 3 VO 4 , 10 mM b-glycerol phosphate and 10 mM NaF. Statistical analysis. P values for ChIP-qPCR and reverse transcription (RT)-PCR were calculated by two-tailed Student's t-tests, type two using Microsoft Excel. The statistical significance of the change of travelling ratio between control and CK2inhibitor-treated samples was determined using two-tailed Kolmogorov-Smirnov test. In yeast experiments, independent transformants that were processed separately were considered biological replicates, and in mammalian experiments, cells cultured in different plates, and processed separately were considered biological replicates. In the analyses, n represents the number of biological replicates. All independent experiments are biological replicates. Identification of ChIP-seq peaks. ChIP-seq peaks were identified using HOMER (http://sdcsb.ucsd.edu/resources/homer/). A 200-bp sliding window was used for transcription factors and a 500-bp sliding window was used for histone modifications with the requirement that two peaks are at least 500 bp apart for transcription factors, and 1,250 bp for histone modifications to avoid redundant peak identification. Tag density was calculated by using HOMER and average signal profiles surrounding androgen-receptor-enriched regions were generated with CEAS 24 (cis-regulatory element annotation system) which were visualized with Java TreeView (http://jtreeview. sourceforge.net).
ChIP-seq alignment. DNA was ligated to specific adaptors followed by highthroughput sequencing on Illumina's HiSeq 2000 system according to the manufacturer's instructions. The first 48 bp for each sequence tag returned was aligned to the hg18 (human) assembly using Bowtie2. The data were visualized by preparing custom tracks on the UCSC genome browser by using HOMER. The total number of mappable reads was normalized to 10 7 for each experiment presented.
ChIP-seq data deposition. ChIP-seq data has been deposited in the Gene Expression Omnibus database under accession number GSE58607. Other published sequencing data used in the study are described in ref. 18 .
Travelling ratio calculation. The Pol II travelling ratio was defined as the relative ratio of Pol II density in the promoter-proximal region and the gene body. The promoter proximal region refers to the window from 250 bp to 1300 bp surrounding the TSS, and the gene body refers to regions from 300 bp downstream of the TSS to 13 kb from the TSS for genes longer than 13 kb, or to the transcription termination site for genes shorter than 13 kb. The significance of the change of the travelling ratio between control and CK2-inhibitor-treated samples was determined by twotailed Kolmogorov-Smirnov test.
In vitro kinase assay and phosphoamino acid analysis (PAA). In vitro kinase reactions were performed with 100 ng of recombinant GST-tagged CK2a (expressed in E. coli with 0.2 mM isopropyl-b-D-thiogalactoside induction for 3 h at 30 uC) in 13 kinase buffer (20 mM Tris-HCl, 50 mM KCl, 10 mM MgCl 2 pH 7.5) with the addition of 0.2 mM ATP for cold reactions (and 10 mM ATP mixed with 10 mCi of [c-32 P]ATP for the radioactive reactions). The substrates (Flag-tagged wild-type H2AX and H2AX(Y57F)) were purified from 293T cells expressing Flag-tagged H2AX constructs. For the full-length proteins, histone extracts were immunoprecipitated using Flag antibody, then washed several times with wash buffer (1% Triton X-100, 900 mM NaCl, 20 mM Tris 8.0), treated with calf intestinal phosphatase for 30 min at 37 uC, washed a few more times with wash buffer, and eluted with 33 Flag peptides. Mononucleosomes were prepared as described 25 with minor changes in microccocal nuclease digestion. In brief, nuclei were isolated from 15-cm fully confluent plates, and DNA was digested in 1.2 ml total volume with 2.5 ml micrococcal nuclease (NEB no. M0247S) for 10 min at 37 uC, and the reaction was stopped by adding 5 mM EGTA, and mononucleosomes were collected by centrifugation. Mononucleosomes were immunoprecipitated with Flag antibody, washed four times with buffer A (340 mM sucrose, 10 mM HEPES pH 7.5, 10% glycerol, 1.5 mM MgCl2, 10 mM KCl) followed by three washes with kinase reaction buffer, then treatment with 500 mM FSBA (Sigma no. F9128-25MG) for 25 min at 37 uC to irreversibly inhibit any potential kinases interacting with the nucleosome. Samples were washed three times with kinase buffer, treated with calf intestinal phosphatase for 30 min at 37 uC, and washed a further three times with buffer A. The bound nucleosomes were eluted with 33 Flag peptides in buffer A. The kinase reactions were carried out for 1 h at 30 uC. For PAA, the samples were separated by SDS-PAGE, transferred to polyvinylidene difluoride membrane, and the membrane corresponding to the mobility of phosphorylated H2AX was excised, and PAA using two-dimensional electrophoresis on thin layer cellulose plates was performed as described 27 .
Whole-cell extracts, immunoprecipitation and cell fractionation. Yeast wholecell extracts were prepared either by breaking the cells with glass beads in PBS or boiling the cells in denaturing buffer (2% SDS with 30 mM dithiothreitol) for 10 min.
To immunoprecipitate the Flag-tagged proteins under denaturing conditions, wholecell extracts were prepared as noted above in denaturing buffer, and the SDS concentration was adjusted to 0.1% by adding dilution buffer (150 mM NaCl, 1% Triton X-100, 20 mM Tris pH 8.0.), then immunoprecipitated overnight using anti-Flag (M2-Sigma) conjugated to agarose beads, and washed five times with dilution buffer. Bound proteins were eluted with 100 mg ml 21 33 Flag peptides in Tris-buffered saline for 30 min at 8 uC twice and the eluted proteins were precipitated using tricholoroacetic acid. In 293T cells, whole-cell extracts for denaturing immunoprecipitation were prepared by boiling the cells in lysis buffer (1% SDS, 20 mM Tris pH 8.0, 10 mM dithiothreitol), and the SDS concentration was adjusted to 0.1% by adding dilution buffer before adding the Flag antibody for immunoprecipitation. Nuclear extracts were prepared using lysis buffer (10 mM HEPES pH 8.0, 1.5 mM MgCl 2 , 10 mM KCl, 1% NP40) to lyse cell membranes; the supernatant is the cytosolic fraction and the pellet is the nuclear fraction. For co-immunoprecipitation, the nuclear pellet was re-suspended in lysis buffer (0.1% NP40, 150 mM NaCl, 20 mM Tris pH 8.0 and 10% glycerol) and sonicated to disrupt the nuclei and chromatin. The antibody and nuclear extract were incubated overnight with 5 mg of CK2a antibody or 20 ml of M2 Flag antibody conjugated to magnetic beads. The beads were washed three times with the same lysis buffer, and the proteins bound to the beads were analysed by mass spectrometry or by immunoblotting. Mass spectrometry. Protein samples were prepared as described 28 . In brief, the protein samples were diluted in TNE buffer (50 mM Tris pH 8.0, 100 mM NaCl, 1 mM EDTA). RapiGest SF reagent (Waters Corp.) was added to the mix to a final concentration of 0.1% and samples were boiled for 5 min. TCEP (Tris (2-carboxyethyl) phosphine) was added to a final concentration of 1 mM and the samples were incubated at 37 uC for 30 min. Subsequently, the samples were carboxymethylated with 0.5 mg ml 21 of iodoacetamide for 30 min at 37 uC followed by neutralization with 2 mM TCEP (final concentration). Proteins samples prepared as above were digested with trypsin (trypsin:protein ratio 1:50) overnight at 37 uC. RapiGest was degraded and removed by treating the samples with 250 mM HCl at 37 uC for 1 h followed by centrifugation at 23,000g for 30 min at 4 uC. The soluble fraction RESEARCH LETTER
